Ccr5 modulators benzimidazoles or benzotriazoles

Details Ccr5 modulators benzimidazoles or benzotriazoles Ccr5 modulators benzimidazoles or benzotriazoles

2006-01-24

2006-01-24

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S253030, C514S300000, C514S318000, C544S336000, C546S118000, C546S193000, C546S199000

Reexamination Certificate

active

06989393

ABSTRACT:
The invention concerns compounds of formula (I), wherein the variables are defined herein; processes for preparing them, compositions comprising them and their use in modulating CCR5 receptor activity.

REFERENCES:
patent: 3318900 (1967-05-01), Janssen
patent: 4126689 (1978-11-01), Sanczuk et al.
patent: 4278677 (1981-07-01), Nedelec et al.
patent: 4410528 (1983-10-01), Teranishi et al.
patent: 5521197 (1996-05-01), Audia
patent: 6172067 (2001-01-01), Ito et al.
patent: 6248755 (2001-06-01), Chapman et al.
patent: 6407121 (2002-06-01), Nagamine et al.
patent: 6432981 (2002-08-01), Finke et al.
patent: 2003/0176693 (2003-09-01), Tsushima et al.
patent: 1 069 124 (2001-01-01), None
patent: 1 122 257 (2001-08-01), None
patent: WO 97/40035 (1997-10-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/17773 (1999-04-01), None
patent: WO 99/36421 (1999-07-01), None
patent: WO 00/08013 (2000-02-01), None
patent: WO 00/38680 (2000-07-01), None
patent: WO 00/59502 (2000-10-01), None
patent: WO 00/76514 (2000-12-01), None
patent: WO 01/25200 (2001-04-01), None
CAS Listing, 77 answers.
Vandenberk et al. “1-benzazolylalkylpiperidines . . . ” CA 87:23274 (1977).
Sato et al. “Psychotropic agents . . . ” CA 89:208915 (1978).
Teranishie et al. “Piperidines derivatives . . . ” CA 95:132947 (1981).
Vartanyan et al. “Synthesis and biological activeity . . . ” CA 98:4503 (1983).
Fukuda et al. “Preparation of benzotriazole . . . ” CA 123:340149 91995).
Cohen et al. “Cytokine function: a study in biologic diversity” CA 125:31527 (1996).
Cowley et al. “Preparation of 1-(3-phenyloxypropyl_piperidine . . . ” CA 138:39189 (2002).
Ahmed et al. “Novel synthesis of 1-aryl-9-alkyl-2,3,3a,4,9,9a-hexahydro . . . ” CA 79:92106 (1973).
Makoto Sato et al., “Psychotropic Agents. 3.14-(4-Substituted piperidinyl)-1-(4-flurophenyl)-1-butanones with Potent Neuroleptic Activity,” Journal of Medicinal Chemistry, vol. 21, No. 11, pp. 1116-1120 (1978).
Ethan Will Taylor et al., “Molecular Determinants for Recognition of RU 24969 Analogs at Central 5-Hydroxytryptamine Recognition Sites: Use of a Bilinear Function and Substituent Volumes to Describe Steric Fit,” Molecular Pharmacology vol. 32, pp. 42-53, (1988).
Nomoto et al., “Studies on Cardiotonic Agents. I. Synthesis if Some Quinazoline Derivatives”,Chem. Pharm. Bull. 38(6):1591-1595 (1990).
Obase et al., “New Antihypertensive Agents. III. Synthesis and Antihypertensive Actvity of Some Arylalkyl Piperidines Carrying a Heterocycle at the 4-Position”,Chem. Pharm. Bull. 31(9):3186-3197 (1983).
Obase et al., “Synthesis of (1-Substituted Piperidin-4-yl)-1H-benzimidazoles and (I-Substituted Piperidin-4-yl)-3,4-dihydroguinazolines as Possible Antihypertensive Agents”,J. Het. Chem.20:565-573 (1983).

Affiliated with

Also associated with

Rating

Ccr5 modulators benzimidazoles or benzotriazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ccr5 modulators benzimidazoles or benzotriazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ccr5 modulators benzimidazoles or benzotriazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3557243